A research blog from the NCI Division of Cancer Prevention Subscribe Trials Test Vaccines for Prevention or Delay of Cancers Associated with Lynch Syndrome February 8, 2023 | By Susan Jenks Researchers have recruited the first vaccine candidates to one of two new prevention trials that seek to immunize high-risk individuals against cancers associated with Lynch syndrome, the most common cause of hereditary colorectal cancer. Individuals who inherit the condition have an estimated lifetime risk as high as 80% for developing one of these malignancies, as well as an above-average risk for cancers arising in other organs, often at an early age, and regardless of race or gender. NCI Funding Approved to Expand Research on Immunoprevention, Natural Products January 10, 2023 | By DCP Staff The National Cancer Institute’s (NCI’s) Board of Scientific Advisors (BSA) recently approved two new concept proposals aimed at expanding potential prevention interventions. One will strengthen research in the nascent field of immunoprevention, and the other will accelerate the development of novel natural products for intercepting cancer at the earliest stages of disease. Leveraging Artificial Intelligence to Improve Accuracy of Lung Cancer Screening December 16, 2022 | By DCP Staff By the time lung cancer is diagnosed, the disease has often already spread outside the lung. Therefore, researchers have sought to develop methods to screen for lung cancer in high-risk populations before symptoms appear. They are evaluating whether the integration of artificial intelligence – the use of computer programs or algorithms that use data to make decisions or predictions – could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. Research Highlights: Learning More about Breast Cancer Prevention in Primary Care Settings November 28, 2022 | By DCP Staff This month’s Research Highlights focuses on provider and patient beliefs about mammogram screening frequency, and separately, provider barriers to engaging in shared decision-making with high-risk patients about the use of chemoprevention to reduce breast cancer risk. Both studies discuss the value of and barriers to using decision-support tools designed to help in the delivery of optimal preventive care. Launching 'CASCADE': A Clinical Trials Network to Optimize Cervical Cancer Screening and Precancer Treatment for the Vulnerable Population of Women Living With HIV November 14, 2022 | By Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. Cervical cancer can be prevented by human papillomavirus (HPV) vaccination and by screening for and treating precancerous lesions. Yet, millions of women globally remain at high-risk for developing cervical cancer. This is especially true for women living in resource-limited settings in low- and middle-income countries (LMICs) where access to prevention services is significantly limited. But this is also true for women facing health disparities within the United States, where half of all cervical cancers occur in women who have never been screened or rarely screened. Research Highlights: Learning More about How Breast Cancer Progresses October 24, 2022 | By DCP Staff This issue of Research Highlights focuses on how cells progress to become breast cancer, and separately, how breast cancer may spread. Understanding these transitional moments can help researchers keep invasive cancer from forming, and help us keep invasive cancer from spreading. One study is about mapping the structural and functional patterns inside breast tissue that distinguish between preinvasive and invasive cancer. The second report describes an increased risk of breast cancer spreading in young women diagnosed within 10 years of childbirth. Common Chemotherapy Drugs Seem to Increase Hearing Loss in Some Adults September 27, 2022 | By Susan Jenks More than half of cancer survivors who were treated with chemotherapy for the four most common types of cancer experienced clinically significant hearing loss and tinnitus after treatment, according to new research. The surprise finding emerged from a cross-sectional study published recently in the British Medical Journal Supportive & Palliative Care involving 273 patients, mostly women, who received either platinum- or taxane-containing drug regimens alone, or in combination, for the treatment of lung, breast, gastrointestinal, or gynecologic cancers. Participants were part of a larger study characterizing chemotherapy-induced peripheral neuropathy (NCT01557608). Samples from People With and Without Cancer Could Help Verify Future Blood Tests to Detect Cancer Early September 15, 2022 | By Susan Jenks Recruitment has begun for a clinical study that investigators hope will move “liquid biopsy” technology closer to its still-distant goal: a single blood test for the early detection of cancer. Collectively known as multi-cancer early detection (MCED) assays or sometimes multi-cancer detection assays (MCD), this new advancing technology is a promising concept for cancer screening, but there are key unanswered questions. Research Highlights: Recently Published Studies on Compounds from Foods and Their Effect of Cancer Risk Measures August 24, 2022 | By DCP Staff Research Highlights are a new type of blog for Cancer Prevention Science, where recent publications are highlighted rather than a traditional news story. This month’s blog post highlights how a cruciferous vegetable extract reduces toxins from tobacco and reports the effects of Polyphenon E in green tea on rectal aberrant crypt foci. Researchers Seek to Care for the Whole Patient August 10, 2022 | By Jack J. Lee, Ph.D. In 2012, Patricia Ganz, M.D., saw a 39-year-old cancer survivor for a consultation who had a long-term history of anxiety during medical visits. The woman had been diagnosed with Hodgkin lymphoma when she was 23 years old. Though her treatment was successful, the cancer returned when she was 25. She received high-dose chemotherapy, a stem cell transplant, and full-dose radiation therapy to the chest. This treatment increased her risk for heart damage and breast cancer. Dr. Ganz recommended continued monitoring for potential late medical effects, as well as psychosocial consultation for her chronic anxiety and symptoms of post-traumatic stress. Pagination 1 2 3 4 … Next › Next page Last » Last page
